In vivo, the anti-tumour efficacy of RGD-Lip-SHK was significantly stronger than that of Free SHK and Lip-SHK, which may be mainly due to the scattered growth of tumour cells in vitro, while in vivo tumour cells grow in clusters. The gene discussed is SHPK; the disease is neoplasm.